Filament Health has developed a groundbreaking platform with the first-ever natural psychedelic drug candidates.
Until now, the healing potential of natural psychedelic drugs has remained largely untapped - hindered by decades of prohibition and the absence of specialized botanical extraction expertise.
At Filament Health, we have developed proprietary technology to create stable, standardized formulations from any psychedelic species. These innovations have yielded patented methods for producing the world’s first pharmaceutical-grade, botanical psychedelic drug candidates, now advancing through clinical trials worldwide.
Psychedelic Botanical Drug Processing Steps:
13 Filed 7 Granted
4 Filed
4 Filed
4 Filed
Filament’s IP is a combination of trade secrets and patented technologies which provide robust protection for our drug candidates, and leverage the known safety profiles of classical psychedelic substances. We secure patent protection for technologies used to extract, purify, stabilize, and standardize our products, as well as for the finished formulations of the drugs we manufacture.
Natural drug development provides a distinct intellectual property advantage.
Unlike synthetic drugs, botanical drugs are complex mixtures derived from natural sources and they are difficult to replicate without precise knowledge of their manufacturing processes. This inherent complexity provides robust protection that extends beyond our issued patents.
While there are countless ways to create synthetic compounds, the methods for extracting, purifying, and standardizing naturally occurring psychedelic compounds are finite, making them much easier to defend through IP.
Filament's research and development facility is one of the first in the world to hold a Health Canada Dealer’s License and be GMP-compliant. These capabilities are required to manufacture and distribute drugs for human consumption in clinical trials or via authorized compassionate use.
OUR industry-leading facility allows us to:
- Propagate psychedelic plants and fungi
- Conduct genetic research
- Develop manufacturing technology
- Generate intellectual property
- Manufacture drug candidates for our own drug development as well as for distribution to drug developers, researchers, and other licensed parties
Filament’s research program includes all natural psychedelics: psilocybin, DMT, harmaline, mescaline, and more.
